Table 1.
Subjects | Gender | Ages | Degrees of differentiation | TNM Stages | Lymphonode metastasis | Relative miR-124 expression |
---|---|---|---|---|---|---|
HCC01 | M | 65 | Low | I | No | 2.11 |
HCC02 | M | 54 | Low | II | No | 0.69 |
HCC03 | M | 56 | Low | II | No | 0.61 |
HCC04 | F | 64 | Low | II | No | 0.42 |
HCC05 | F | 65 | Low | III | Yes | 0.68 |
HCC06 | M | 40 | Low | II | No | 0.71 |
HCC07 | M | 50 | High | II | No | 2.75 |
HCC08 | F | 57 | High | II | No | 0.20 |
HCC09 | M | 49 | Low | II | No | 0.27 |
HCC10 | M | 56 | Medium | III | Yes | 0.16 |
HCC11 | M | 56 | Medium | I | No | 0.25 |
HCC12 | F | 21 | High | II | No | 0.23 |
HCC13 | M | 59 | High | III | Yes | 0.08 |
HCC14 | M | 62 | Low | III | Yes | 0.10 |
HCC15 | M | 59 | Medium | II | No | 1.22 |
HCC16 | M | 59 | Medium | I | No | 1.32 |
HCC17 | M | 47 | Low | II | No | 0.34 |
HCC18 | M | 42 | Low | II | No | 0.03 |